Microglial Activation and Connectivity in Alzheimer Disease and Aging

Alzheimer disease (AD) is characterized by amyloid β (Aβ) plaques and neurofibrillary tau tangles, but increasing evidence suggests that neuroinflammation also plays a key role, driven by the activation of microglia. Aβ and tau pathology appear to spread along pathways of highly connected brain regions, but it remains elusive whether microglial activation follows a similar distribution pattern. Here, we assess whether connectivity is associated with microglia activation patterns.

[1]  A. Drzezga,et al.  Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases , 2021, Science Translational Medicine.

[2]  K. Blennow,et al.  Microglial activation and tau propagate jointly across Braak stages , 2021, Nature Medicine.

[3]  H. Adelsberger,et al.  Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation , 2021, bioRxiv.

[4]  A. Danek,et al.  Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome , 2021, Frontiers in Aging Neuroscience.

[5]  Sebastian Schuster,et al.  Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders , 2021, Life.

[6]  Yi Wang,et al.  Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study , 2021, Inf. Fusion.

[7]  J. Mulder,et al.  Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease , 2021, Acta Neuropathologica.

[8]  M. Tremblay,et al.  Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models , 2020, Frontiers in Cellular Neuroscience.

[9]  Ukpong B. Eyo,et al.  Negative feedback control of neuronal activity by microglia , 2020, Nature.

[10]  A. Danek,et al.  TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. , 2020, Clinical nuclear medicine.

[11]  K. Bötzel,et al.  In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies , 2020, medRxiv.

[12]  Keith A. Johnson,et al.  Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease , 2020, Nature Communications.

[13]  R. Perneczky,et al.  Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid. , 2020, Journal of Alzheimer's disease : JAD.

[14]  Rik Ossenkoppele,et al.  Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity , 2019, eLife.

[15]  T. Hromádka,et al.  Intersection of pathological tau and microglia at the synapse , 2019, Acta neuropathologica communications.

[16]  Sang Won Seo,et al.  Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease , 2019, Brain : a journal of neurology.

[17]  K. Cosgrove,et al.  Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study , 2019, bioRxiv.

[18]  P. Expert,et al.  Covariance statistics and network analysis of brain PET imaging studies , 2019, Scientific Reports.

[19]  Alan C. Evans,et al.  Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease , 2019, bioRxiv.

[20]  T. Schneider-Axmann,et al.  CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum , 2019, Neurobiology of Aging.

[21]  L. Tan,et al.  Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  J. Trojanowski,et al.  Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology , 2019, Molecular Neurodegeneration.

[23]  D. Holtzman,et al.  Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE , 2018, Nature Neuroscience.

[24]  N. Albert,et al.  Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study , 2018, Journal of Neuroinflammation.

[25]  Derek H. Oakley,et al.  The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease , 2018, Journal of Neuroinflammation.

[26]  B. Lamb,et al.  Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.

[27]  D. Brooks,et al.  Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease , 2018, Brain : a journal of neurology.

[28]  C. Steinhäuser,et al.  Plaque‐dependent morphological and electrophysiological heterogeneity of microglia in an Alzheimer's disease mouse model , 2018, Glia.

[29]  D. Brooks,et al.  Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. , 2018, Journal of Alzheimer's disease : JAD.

[30]  F. Jessen,et al.  Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) , 2018, Alzheimer's Research & Therapy.

[31]  Luca Passamonti,et al.  Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy , 2018, Brain : a journal of neurology.

[32]  R. Mizrahi,et al.  Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  W. Jagust,et al.  Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.

[34]  John L. Robinson,et al.  TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss , 2017, Neuron.

[35]  Paul Edison,et al.  An early and late peak in microglial activation in Alzheimer’s disease trajectory , 2017, Brain : a journal of neurology.

[36]  Yu Zhang,et al.  The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.

[37]  Paul Edison,et al.  Neuroinflammation in Alzheimer's disease: Current evidence and future directions , 2016, Alzheimer's & Dementia.

[38]  K. Blennow,et al.  sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers , 2016, EMBO molecular medicine.

[39]  Paul Edison,et al.  Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. , 2015, Brain : a journal of neurology.

[40]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[41]  Claire Paquet,et al.  Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study , 2015, Alzheimer's Research & Therapy.

[42]  J. D. Kruschwitz,et al.  GraphVar: A user-friendly toolbox for comprehensive graph analyses of functional brain connectivity , 2015, Journal of Neuroscience Methods.

[43]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[44]  R. Mayeux,et al.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.

[45]  Francis J McMahon,et al.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. , 2013, Brain : a journal of neurology.

[46]  Kimberly J. Jenko,et al.  A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  Frederik Barkhof,et al.  Microglial activation in healthy aging , 2012, Neurobiology of Aging.

[48]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[49]  J. Growdon,et al.  Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. , 2011, The American journal of pathology.

[50]  Christer Halldin,et al.  Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine , 2011, NeuroImage.

[51]  Gerald van Belle,et al.  Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.

[52]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[53]  M F Weiner,et al.  A total score for the CERAD neuropsychological battery , 2005, Neurology.

[54]  D. Mann,et al.  Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease , 2002, Neuroscience Letters.

[55]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[56]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[57]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[58]  R. Innis,et al.  Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia. , 2018, Advances in pharmacology.

[59]  J. Sheridan,et al.  Microglia Priming with Aging and Stress , 2017, Neuropsychopharmacology.

[60]  Jan Sijbers,et al.  ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data , 2009 .

[61]  F. LaFerla,et al.  Microglia as a potential bridge between the amyloid beta-peptide and tau. , 2004, Annals of the New York Academy of Sciences.